ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Bayer’s new haemophilia A drug obtains FDA approval
pharmaceutical-technology
September 03, 2018Bayer has received approval from the US Food and Drug Administration (FDA) for its new haemophilia A drug Jivi (BAY94-9027) as routine prophylactic therapy in previously treated adults and adolescents aged 12 years and above.
Pharma Sources Insight July 2025
